This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Takahiko Satoh: Innovator in Antiarrhythmic Compounds
Introduction
Takahiko Satoh is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antiarrhythmic activity. His work is characterized by a commitment to innovation and a focus on improving medical treatments.
Latest Patents
Takahiko Satoh holds a patent for 5-(4-piperidinyl)dibenzothiazepine derivatives. The objective of this invention is to provide a compound that exhibits antiarrhythmic activity. The patent details a compound of formula (I), where various substituents are defined, including R¹ and R², which can represent hydrogen, halogen, or lower alkyl groups. The invention also encompasses pharmaceutically acceptable salts and solvates of the compound.
Career Highlights
Satoh is associated with Meiji Seika Kaisha, Ltd., a company known for its advancements in the pharmaceutical industry. His work at the company has been instrumental in developing new therapeutic agents that address critical health issues.
Collaborations
Throughout his career, Takahiko Satoh has collaborated with esteemed colleagues, including Kiyoaki Katano and Tomoko Soneda. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Takahiko Satoh's contributions to the field of pharmaceuticals, particularly through his patent for antiarrhythmic compounds, highlight his role as a significant inventor. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile